Drug application
ESKALITH CR (LITHIUM CARBONATE)
Drugs@FDA NDA 018152 · JDS PHARMS
Key facts
| Drug name | ESKALITH CR |
|---|---|
| Active ingredients | LITHIUM CARBONATE |
| Application type | NDA |
| Application number | 018152 |
| Company | JDS PHARMS |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | 450MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Mar 29, 1982 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: